Trisenox IV infusion 12mg (Arsenic trioxide) from Nippon Shinyaku (YJ_code: 4291409A2021, 12mg 6mL 1 bottle) is an antineoplastic agent. It is indicated for the treatment of acute promyelocytic leukemia (APL) that is refractory to retinoid and anthracycline chemotherapy, or for patients with relapsed APL.
Trisenox IV infusion 12mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →